Case Report: early regression and bladder-intact survival after limited-course immunotherapy-based systemic therapy in two patients with clinically staged bulky muscle-invasive bladder cancer. - Zhang S; Zhang H; Dong X; Qi Z; Ma Y; Chang H; Li Y; Zhang W (Frontiers in immunology, 2026)